Partners

At Indica Labs, we’ve built an ecosystem of partnerships to promote open pathology and interoperability, enabling our customers to choose best-of-breed products across integrated digital pathology workflows.

ACD, a Bio-Techne brand

ACD, a Bio-Techne brand, with proprietary RNAscope™ Technology, the first multiplex fluorescent and chromogenic ISH platform, enables multiomic RNA and Protein detection within spatial context. 

Our portfolio includes RNAscope, BaseScope™, miRNAscope™, RNAscope Plus, Multiplex Fluorescent V2 and HiPlex™ v2. With 49,000+ unique probes, 9,900+ articles, and our Professional Assay Services, we enable rapid visualization of unique targets. 

Learn More 

Lunaphore, a Bio-Techne brand

Lunaphore – a Bio-Techne brand, was born with the vision of enabling spatial biology in every laboratory. Lunaphore empowers researchers to push the boundaries of scientific discovery and drug development. Its flagship COMET™ platform is a fully automated, high-throughput, hyperplex platform offering scalability and reproducibility without the need for conjugation. 

Learn More 

Akoya Biosciences

Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. We offer comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. 

Learn More 

Dell

Dell Technologies provides solutions to help healthcare and life sciences organizations manage the data growth associated with digital pathology by providing scalable, performant, and secure IT infrastructure. Our solutions power computational pathology and AI applications while simplifying the management of whole slide imaging data from within the data center and to the cloud. 

Learn More 

Lunit

Lunit develops AI-powered medical image analysis software via cutting-edge deep learning technology. Our systems can help physicians make accurate and efficient clinical decisions through data-driven imaging biomarkers, improving cancer therapy outcomes. 

Learn More 

Merge by Merative

Merge medical imaging solutions, offered by Merative, combine intelligent, scalable imaging workflow tools with deep and broad expertise to help healthcare organizations improve their confidence in patient outcomes and optimize care delivery.   

Learn More 

Xyall

Xyall is active in the field of oncology based molecular diagnostic testing. Xyall is on a mission to optimize molecular diagnostic test results for cancer patients with their fully automated Tissector solutions that enable accurate and efficient selection of tumor samples. 

Learn More 

Deep Bio is an AI healthcare company focusing on deep learning to advance the field of cancer pathology. Its flagship product, DeepDx® Prostate, is an AI-powered software for the assessment of prostate cancer on digital whole slide images, providing Gleason grading, percent tumor involvement, and tumor-to-tissue measurements. 

Learn More 

ACD, a Bio-Techne brand

ACD, a Bio-Techne brand, with proprietary RNAscope™ Technology, the first multiplex fluorescent and chromogenic ISH platform, enables multiomic RNA and Protein detection within spatial context. 

Our portfolio includes RNAscope, BaseScope™, miRNAscope™, RNAscope Plus, Multiplex Fluorescent V2 and HiPlex™ v2. With 49,000+ unique probes, 9,900+ articles, and our Professional Assay Services, we enable rapid visualization of unique targets. 

Learn More 

Lunaphore, a Bio-Techne brand

Lunaphore – a Bio-Techne brand, was born with the vision of enabling spatial biology in every laboratory. Lunaphore empowers researchers to push the boundaries of scientific discovery and drug development. Its flagship COMET™ platform is a fully automated, high-throughput, hyperplex platform offering scalability and reproducibility without the need for conjugation. 

Learn More 

Akoya Biosciences

Our mission is to bring context to the world of biology and human health through the power of spatial phenotyping. We offer comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. 

Learn More 

Dell

Dell Technologies provides solutions to help healthcare and life sciences organizations manage the data growth associated with digital pathology by providing scalable, performant, and secure IT infrastructure. Our solutions power computational pathology and AI applications while simplifying the management of whole slide imaging data from within the data center and to the cloud. 

Learn More 

Lunit

Lunit develops AI-powered medical image analysis software via cutting-edge deep learning technology. Our systems can help physicians make accurate and efficient clinical decisions through data-driven imaging biomarkers, improving cancer therapy outcomes. 

Learn More 

Xyall

Xyall is active in the field of oncology based molecular diagnostic testing. Xyall is on a mission to optimize molecular diagnostic test results for cancer patients with their fully automated Tissector solutions that enable accurate and efficient selection of tumor samples. 

Learn More 

Deep Bio is an AI healthcare company focusing on deep learning to advance the field of cancer pathology. Its flagship product, DeepDx® Prostate, is an AI-powered software for the assessment of prostate cancer on digital whole slide images, providing Gleason grading, percent tumor involvement, and tumor-to-tissue measurements. 

Learn More 

Merge by Merative

Merge medical imaging solutions, offered by Merative, combine intelligent, scalable imaging workflow tools with deep and broad expertise to help healthcare organizations improve their confidence in patient outcomes and optimize care delivery.   

Learn More